4 
 
 
 
CLINICAL  STUDY  PROTOCOL 
IND 116542  
 
 
A Double -Masked,  Randomize d, Multicenter,  Placebo -Controlle d, 
Parallel -Group  Study  of SJP-0035  Ophthalmic  Solution  Compared  with 
Placebo  to Assess  Safety  and Efficacy  of Two Dose  Concentrations  of 
SJP-0035  Ophthalmic  Solution  for Corneal  Epi[INVESTIGATOR_686138].:  SJP-0035/2 -02 
 
Sponsor:  Senju  Phannac eutical Co., Ltd. 
2-5-8, Hiranomach i, Chuo -Ku 
Osaka  541-0046,  Japan  
Sponsor  Contact:  
 
 
 
[CONTACT_686139]:   1.0 
 
 
Date  of Protocol:   27 April2016  
 
 
CONFIDENTIAL  
All financial  and nonfinancial  suppo1t for this study  will be provided  by [CONTACT_686140]., Ltd. The concepts  and info1mation  contained  in this document  or generated  during the 
study are considered  proprietary  and may not be disclosed  in whole  or in part without  the 
expresse d,  written  consent  of Senju  Pharmaceutical Co., Ltd. 
The sn1dy  will be conducted  according  to the Intemat ional Council  on Harmon isation  
harmo nised  tripa1tite guideline  E6(Rl): Good  Clinical  Practice. 
A redacted v ersion of  the Protocol, cont aining the Statistical Analysis Plan (SAP) is b eing 
prepared and will  be uploaded in due course. 